Sensura Marks a Milestone at CES 2026 with Its Non-Invasive Health Monitoring Platform
Singapore & Las Vegas | January 2026
Sensura, a Singapore-based deep-tech company focused on next-generation health and wellness monitoring solutions, marked a significant milestone at CES® 2026, where it showcased its non-invasive health monitoring platform to a global audience across healthcare, technology, and innovation ecosystems.
During the four-day exhibition in Las Vegas, Sensura presented its latest prototype platform for non-invasive glucose monitoring and engaged with clinicians, industry experts, media, and potential partners on the growing demand for painless, continuous, and user-centric health monitoring solutions.
Strong Presence and Industry Engagement at CES 2026
At CES 2026, Sensura introduced a unified non-invasive health monitoring platform powered by its proprietary optical sensing technology, custom chip architecture, and AI-driven analytics. The showcase featured two complementary prototypes: a portable device designed for quick, non-invasive spot checks, and a wearable form factor for continuous glucose trend monitoring throughout the day.
These devices aim to help users understand how daily behaviors—such as diet, exercise, and sleep—affect metabolic health, all while eliminating the pain and inconvenience associated with traditional glucose monitoring. With these innovations, Sensura aims to empower individuals to take control of their health in a seamless and sustainable manner.
Wearable Health Monitoring Gains Momentum at CES 2026
CES 2026 underscored a clear industry shift toward wearable health technologies, with a growing emphasis on preventive care, real-time data, and continuous monitoring. Sensura’s non-invasive approach positioned it among the innovators leading this shift, reflecting the increasing demand for health solutions that are not only effective but also comfortable and adaptable to everyday life. This trend marks the dawn of a new era in healthcare, where wearable technologies play a central role in preventive and personalized wellness.
International Media Coverage and Third-Party Recognition
Sensura’s CES 2026 showcase gained significant recognition from international media and industry organizations, reinforcing the growing global relevance of non-invasive health monitoring:
These recognitions affirm the significance of Sensura’s approach and its potential to make a profound impact on global healthcare.
Executive Commentary
Looking Ahead
Following CES 2026, Sensura will continue advancing its product development, clinical validation efforts, and strategic collaborations globally. The company remains focused on translating advanced sensing technologies into practical, everyday health solutions that support earlier intervention, better adherence, and improved long-term health outcomes.
About Sensura
Sensura is a Singapore-based deep-tech company focused on developing next-generation health and wellness monitoring solutions. By combining proprietary optical sensing technology, custom chip architecture, and AI-driven analytics, Sensura aims to make health monitoring personalized, painless, and accessible. Beginning with non-invasive glucose monitoring, the company’s platform is designed to expand over time into broader health indicators that support preventive and personalized care.
Related Media Coverage
Sensura’s CES 2026 showcase and technology platform were featured by leading international media and industry organizations: